IBD News

May 4, 2015May 4, 2015

Lycera Announces Initiation of Phase 1 Clinical Trial of Experimental Inflammatory Bowel Disease Therapy

IBD News, News

Lycera Corp., a biopharmaceutical company that develops novel oral immune modulators to treat autoimmune conditions and cancer, recently announced the start of a new Phase 1 clinical study of its ... Read more

April 30, 2015April 30, 2015

Mount Sinai Awarded $3 Million For Inflammatory Bowel Disease Center

IBD News, News

Founded by the renowned philanthropist and economist Sanford J. Grossman, The Sanford J. Grossman Charitable Trust was recently awarded $3 million to establish the Dr. Sanford J. Grossman Center for Integrative ... Read more

April 29, 2015April 29, 2015

Industry and Academe Team Up To Develop Microbiome-based Therapies For Patients With Inflammatory Bowel Disease

IBD News, News

San Francisco based Second Genome, Inc., a biotech firm specializing in novel medicine development through applied innovative microbiome science, has formed an alliance with the University College Cork (UCC), Ireland’s ... Read more

April 23, 2015September 28, 2016

World IBD Day Video Campaign Already Ongoing

IBD News, News

World IBD Day is taking place on May 19, and more than 40 different nations throughout the world are already preparing to participate in the celebration. The initiative is organized every year on the ... Read more

April 15, 2015April 15, 2015

Chronic Inflammation and Immunosuppressive Therapy Increases IBD-associated Colorectal Cancer Risk

IBD News, News

A recent review entitled “Cancers Complicating Inflammatory Bowel Disease” described an association between the risk for several types of cancers in patients with inflammatory bowel disease due to chronic intestinal ... Read more

April 3, 2015April 3, 2015

Qu Biologics Granted US Patent For Use Of E. Coli To Treat Crohn’s Disease

IBD News, News

Qu Biologics Inc., a biotechnology firm currently developing Site Specific Immunomodulators (SSIs) to restore regular immune function in a specific targeted diseased organ, recently announced that the United States Patent and Trademark Office issued a U.S. ... Read more

April 2, 2015April 2, 2015

Inflammatory Bowel Disease Linked to Urolithiasis, Urinary Tract infection

IBD News, News

In a recent study, a research team led by Dr. Bhojani from the Division of Urology, Université de Montréal in Montreal, Canada and colleagues found that compared to the general ... Read more

April 1, 2015April 1, 2015

Laparoscopic Colectomy Costs Less than Open Colectomy for IBD

IBD News, News

A new study published in the March 25 online edition of JAMA Surgery has shown that people who underwent a laparoscopic colectomy needed fewer days of health care. Their acute and follow-up care also costed ... Read more

March 31, 2015March 31, 2015

Study Finds Link Between Inflammatory Bowel Disease, Neoplastic Lesions of the Uterine Cervix

IBD News, News

According to a recent population-based study, there is a 2-way association between inflammatory bowel disease (IBD), particularly Crohn’s disease, and neoplastic lesions of the uterine cervix. The findings also showed ... Read more

March 27, 2015March 27, 2015

Lycera and Merck Reach Milestone in Collaboration for IBD Therapy

IBD News, News

Lycera Corp. has reached a milestone in its collaboration agreement with Merck on the study and development of small molecule therapeutic candidates to address a series of immune-mediated disorders, including inflammatory bowel diseases (IBD). ... Read more